303 related articles for article (PubMed ID: 17125260)
1. Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.
El-Tayeb A; Qi A; Müller CE
J Med Chem; 2006 Nov; 49(24):7076-87. PubMed ID: 17125260
[TBL] [Abstract][Full Text] [Related]
2. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
[TBL] [Abstract][Full Text] [Related]
3. Structure activity and molecular modeling analyses of ribose- and base-modified uridine 5'-triphosphate analogues at the human P2Y2 and P2Y4 receptors.
Jacobson KA; Costanzi S; Ivanov AA; Tchilibon S; Besada P; Gao ZG; Maddileti S; Harden TK
Biochem Pharmacol; 2006 Feb; 71(4):540-9. PubMed ID: 16359641
[TBL] [Abstract][Full Text] [Related]
4. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.
Nicholas RA; Watt WC; Lazarowski ER; Li Q; Harden K
Mol Pharmacol; 1996 Aug; 50(2):224-9. PubMed ID: 8700127
[TBL] [Abstract][Full Text] [Related]
5. Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.
El-Tayeb A; Qi A; Nicholas RA; Müller CE
J Med Chem; 2011 Apr; 54(8):2878-90. PubMed ID: 21417463
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the expression of multiple uracil nucleotide-stimulated P2 receptors coupled to smooth muscle contraction in porcine isolated arteries.
Rayment SJ; Latif ML; Ralevic V; Alexander SP
Br J Pharmacol; 2007 Mar; 150(5):604-12. PubMed ID: 17262017
[TBL] [Abstract][Full Text] [Related]
7. P2 receptors activated by uracil nucleotides--an update.
Brunschweiger A; Müller CE
Curr Med Chem; 2006; 13(3):289-312. PubMed ID: 16475938
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.
Ko H; Carter RL; Cosyn L; Petrelli R; de Castro S; Besada P; Zhou Y; Cappellacci L; Franchetti P; Grifantini M; Van Calenbergh S; Harden TK; Jacobson KA
Bioorg Med Chem; 2008 Jun; 16(12):6319-32. PubMed ID: 18514530
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors. SER-333 and SER-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor.
Brinson AE; Harden TK
J Biol Chem; 2001 Apr; 276(15):11939-48. PubMed ID: 11114308
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors.
Nicholas RA; Lazarowski ER; Watt WC; Li Q; Boyer J; Harden TK
J Auton Pharmacol; 1996 Dec; 16(6):319-23. PubMed ID: 9131407
[TBL] [Abstract][Full Text] [Related]
11. Apical P2Y4 purinergic receptor controls K+ secretion by vestibular dark cell epithelium.
Marcus DC; Scofield MA
Am J Physiol Cell Physiol; 2001 Jul; 281(1):C282-9. PubMed ID: 11401851
[TBL] [Abstract][Full Text] [Related]
12. 5-OMe-uridine-5'-O-(α-boranodiphosphate), a novel nucleotide derivative highly active at the human P2Y(6) receptor protects against death-receptor mediated glial apoptosis.
Haas M; Ginsburg-Shmuel T; Fischer B; Reiser G
Neurosci Lett; 2014 Aug; 578():80-4. PubMed ID: 24970757
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.
Ivanov AA; Ko H; Cosyn L; Maddileti S; Besada P; Fricks I; Costanzi S; Harden TK; Calenbergh SV; Jacobson KA
J Med Chem; 2007 Mar; 50(6):1166-76. PubMed ID: 17302398
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta.
Guns PJ; Korda A; Crauwels HM; Van Assche T; Robaye B; Boeynaems JM; Bult H
Br J Pharmacol; 2005 Sep; 146(2):288-95. PubMed ID: 15997227
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of uridine 5'-diphosphate analogues at the human P2Y6 receptor.
Besada P; Shin DH; Costanzi S; Ko H; Mathé C; Gagneron J; Gosselin G; Maddileti S; Harden TK; Jacobson KA
J Med Chem; 2006 Sep; 49(18):5532-43. PubMed ID: 16942026
[TBL] [Abstract][Full Text] [Related]
16. P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts.
Korcok J; Raimundo LN; Du X; Sims SM; Dixon SJ
J Biol Chem; 2005 Apr; 280(17):16909-15. PubMed ID: 15722352
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of agonist-dependent and -independent desensitization of a recombinant P2Y2 nucleotide receptor.
Otero M; Garrad RC; Velázquez B; Hernández-Pérez MG; Camden JM; Erb L; Clarke LL; Turner JT; Weisman GA; González FA
Mol Cell Biochem; 2000 Feb; 205(1-2):115-23. PubMed ID: 10821429
[TBL] [Abstract][Full Text] [Related]
18. K+ secretion activated by luminal P2Y2 and P2Y4 receptors in mouse colon.
Matos JE; Robaye B; Boeynaems JM; Beauwens R; Leipziger J
J Physiol; 2005 Apr; 564(Pt 1):269-79. PubMed ID: 15718265
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
von Kügelgen I
Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
[TBL] [Abstract][Full Text] [Related]
20. Human keratinocytes express multiple P2Y-receptors: evidence for functional P2Y1, P2Y2, and P2Y4 receptors.
Burrell HE; Bowler WB; Gallagher JA; Sharpe GR
J Invest Dermatol; 2003 Mar; 120(3):440-7. PubMed ID: 12603858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
